Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1217-1230

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chung, B. H.
Right arrow Articles by Darnell, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chung, B. H.
Right arrow Articles by Darnell, B. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHOLESTEROL
Medline Plus Health Information
*Diets
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1217-1230.)
© 1998 American Heart Association, Inc.


Original Contributions

Potencies of Lipoproteins in Fasting and Postprandial Plasma to Accept Additional Cholesterol Molecules Released From Cell Membranes

Byung Hong Chung; Frank Franklin; B. H. Simon Cho; J. P. Segrest; Karen Hart; ; Betty E. Darnell

From the Atherosclerosis Research Unit, Department of Medicine (B.H.C., J.P.S., K.H.), the Department of Pediatrics (F.F.), and the Clinical Research Center (B.H.S.C.), University of Alabama at Birmingham; and the H.E. Moore Heart Research Foundation, University of Illinois, Champaign (B.E.D.).

Correspondence to Byung Hong Chung, PhD, Atherosclerosis Research Unit, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294. E-mail Chung{at}aru.dom.uab.edu

Abstract—To investigate the role of various lipoproteins in plasma to promote cholesterol efflux from cell membranes, potencies of lipoproteins in normolipidemic fasting and postprandial (PP) plasmas to accept additional cholesterol molecules from cell membranes were determined. We used red blood cells (RBCs) and lipoproteins in fresh blood as donors and acceptors of cell membrane cholesterol, respectively. When fresh fasting plasma (n=24) containing active lecithin:cholesterol acyltransferase (LCAT) and cholesteryl ester transfer proteins (CETP) was incubated with a 3-fold excess of autologous RBCs at 37°C for 18 hours, plasma cholesterol levels increased by 19.6% (38.5±14.2 mg/dL) owing to an exclusive increase in the CE level. Very low density lipoprotein (VLDL), low density lipoprotein (LDL), and high density lipoprotein (HDL) fractions retained 48.1%, 26.3%, and 25.6% of the net cholesterol mass increase in fasting plasma, resulting in 91%, 8%, and 21% increases in their cholesterol contents, respectively. The PP plasma was 1.3-fold more potent than fasting plasma in promoting cholesterol efflux from RBCs by associating excess cholesterol with chylomicrons, resulting in a 356% increase in the cholesterol content of chylomicrons. These increases in lipoprotein cholesterol content indicate that chylomicrons were about 3.9x, 44x, and 17x more potent than fasting VLDL, LDL, and HDL, respectively, in accepting additional cholesterol molecules released from RBCs. The capacity of PP plasma to promote cholesterol efflux from RBCs was significantly correlated with plasma cholesterol levels (r=0.60, P<0.005), triglycerides (r=0.68, P<0.001), chylomicrons (r=0.90, P<0.001), VLDL (r=0.65, P<0.001), and LDL (r=0.47, P<0.025) but not with the levels of HDL (r=-0.34, P<0.20). In fasting plasma containing a low level of VLDL and HDL, isolated chylomicrons supplemented to the plasma were {approx}9x more potent than HDL in boosting the capacity of plasma to promote cholesterol efflux from RBCs. This study indicates that chylomicrons in PP plasma are the most potent ultimate acceptors of cholesterol released from cell membranes and that a low HDL level is not a factor that limits the ability of PP plasma to promote cholesterol efflux from cell membranes. Our data obtained from an in vitro system suggest that PP chylomicrons may play a major role in promoting reverse cholesterol transport in vivo, since the transfer of cholesterol from cell membranes to chylomicrons will lead to the rapid removal of this cholesterol by the liver. HDL in vivo may promote reverse cholesterol transport by enhancing the rapid removal of chylomicrons from the circulation, since the rate of clearance of chylomicrons is positively correlated with the HDL level in plasma.


Key Words: chylomicrons • HDL • lecithin:cholesterol acyltransferase • cholesteryl ester transfer proteins • reverse cholesterol transport




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. H.E.M. Klerkx, K. E. Harchaoui, W. A. van der Steeg, S. M. Boekholdt, E. S.G. Stroes, J. J.P. Kastelein, and J. A. Kuivenhoven
Cholesteryl Ester Transfer Protein (CETP) Inhibition Beyond Raising High-Density Lipoprotein Cholesterol Levels: Pathways by Which Modulation of CETP Activity May Alter Atherogenesis
Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 706 - 715.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B.-H. Chung, B. S. Cho, P. Liang, S. Doran, L. Osterlund, R. A Oster, B. Darnell, and F. Franklin
Contribution of postprandial lipemia to the dietary fat-mediated changes in endogenous lipoprotein-cholesterol concentrations in humans
Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1145 - 1158.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B.-H. Chung, P. Liang, S. Doran, B. H. S. Cho, and F. Franklin
Postprandial chylomicrons: potent vehicles for transporting cholesterol from endogenous LDL+HDL and cell membranes to the liver via LCAT and CETP
J. Lipid Res., July 1, 2004; 45(7): 1242 - 1255.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B.-H. Chung, S. Doran, P. Liang, L. Osterlund, B. S. Cho, R. A Oster, B. Darnell, and F. Franklin
Alcohol-mediated enhancement of postprandial lipemia: a contributing factor to an increase in plasma HDL and a decrease in risk of cardiovascular disease
Am. J. Clinical Nutrition, September 1, 2003; 78(3): 391 - 399.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Guerin, P. Egger, C. Soudant, W. Le Goff, A. van Tol, R. Dupuis, and M. J. Chapman
Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state
J. Lipid Res., October 1, 2002; 43(10): 1652 - 1660.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. E. Christian, H.-S. Byun, N. Zhong, M. Wanunu, T. Marti, A. Fürer, F. Diederich, R. Bittman, and G. H. Rothblat
Comparison of the capacity of {beta}-cyclodextrin derivatives and cyclophanes to shuttle cholesterol between cells and serum lipoproteins
J. Lipid Res., August 1, 1999; 40(8): 1475 - 1482.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
L. F. Tinker, E. J Parks, S. R. Behr, B. O. Schneeman, and P. A. Davis
(n-3) Fatty Acid Supplementation in Moderately Hypertriglyceridemic Adults Changes Postprandial Lipid and Apolipoprotein B Responses to a Standardized Test Meal
J. Nutr., June 1, 1999; 129(6): 1126 - 1134.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
G. H. Rothblat, M. de la Llera-Moya, V. Atger, G. Kellner-Weibel, D. L. Williams, and M. C. Phillips
Cell cholesterol efflux: integration of old and new observations provides new insights
J. Lipid Res., May 1, 1999; 40(5): 781 - 796.
[Abstract] [Full Text]